A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer
Recruiting · NCT05327647 · Registry updated 2025-12-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Non-Muscle Invasive Bladder Neoplasms, Urogenital Diseases, Urogenital Neoplasms, benign urinary system neoplasm, carcinoma, epithelial neoplasm, neoplasm, urinary bladder disorder, urinary bladder neoplasm, urinary system disorder | Recruiting | Phase 2 | 2025-12-18 | NCT05327647 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Institutes of Health Research (CIHR) | 339 |
| Cancer Research Society | 6 |
| CHU de Quebec-Universite Laval | 54 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Hospitalier de l'Université De Montréal_CHUM | Montreal | Canada | 1 |
| Centre intégré de santé et services sociaux de Chaudière Appalaches | Lévis | Canada | 1 |
| CHU de Québec-Université Laval | Québec | Canada | 2 |
| CIUSSS de l'Estrie - CHUS | Sherbrooke | Canada | 2 |
| London Health Sciences Centre | London | Canada | 58 |
| McGill University Health Centre_CUSM | Montreal | Canada | 1 |
| University Health Network, Princess Margaret Cancer Centre | Toronto | Canada | 2 |